CDX2 and breast cancer: miR-181d-5p contained in CAF-derived EVs in breast cancer promotes proliferation, invasion, migration, and EMT and inhibits apoptosis of cancer cells by targeting caudal-related homeobox 2 (CDX2) and downregulating CDX2 and their downstream gene homeoboxA5 (HOXA5) [40].